Mednet Logo

Related Questions

How would you approach a vulvar SCC with extension to the anal sphincter and inguinal nodes, 10 years after definitive chemoRT+brachy for a cervical cancer?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I have treated few in this situation. Limited to treating vulva, anal canal with the inguinal region with boost to GTV to 66 Gy EQ2 dose with concurrent cisplatinum, avoided any prophylactic nodal region including mesorectum or pelvic nodal region.

How do you approach RT coverage of an abdominopelvic lymph node in the oligometastatic or oligorecurrent setting?

3
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · MD Anderson Cancer Center

Speaking specifically about prostate cancer, after treating a number of these with SBRT and having them fail in an adjacent node, me and everyone in our group will tend to treat the entire nodal chain with an SIB to the grossly involved LNs. The only exceptions are in those patients where prior RT p...

When do you consider re-irradiating patients with recurrent cervical cancer?

3
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Kentucky

Because I have been seeing and treating a reasonable number of these cases for 35 years, I have some strong opinions on the matter. Although external beam re-irradiation in the setting of recurrent cervical cancer is fraught with great hazards and poor outcomes, interstitial re-irradiation has a hig...

What is your thought process for dose prescriptions when treating abdominal/pelvic lymph node oligometastasis with SBRT?

3
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic

I don't love SBRT for nodal mets aside from unique situations. Although I agree they may represent a less aggressive phenotype than hematologic parenchymal mets they are also connected to their neighbors in a way a bone met isn't. SBRT is a very focal therapy when done well and so neighboring LNs do...